
  
    
      
        Background_NNP
        "_'' Indeed_RB ,_, between_IN the_DT health_NN care_NN that_IN we_PRP now_RB have_VBP ,_, and_CC
        the_DT health_NN care_NN we_PRP could_MD have_VB ,_, lies_VBZ not_RB just_RB a_DT gap_NN ,_, but_CC a_DT
        chasm_NN ._. "_'' Crossing_NNP the_DT Quality_NNP Chasm_NNP :_: A_DT New_NNP Health_NNP System_NNP for_IN
        the_DT 21_CD stCentury_NN [_NN 1_CD ]_NN ._.
        When_WRB the_DT Institute_NNP of_IN Medicine_NNP recently_RB assessed_VBD the_DT
        current_JJ state_NN of_IN affairs_NNS in_IN U_NNP ._. S_NNP ._. health_NN care_NN ,_, they_PRP found_VBD it_PRP
        to_TO be_VB substantially_RB lacking_VBG in_IN key_JJ areas_NNS [_NN 1_CD ]_NN ._. The_DT
        report_NN 's_POS authors_NNS identified_VBD a_DT multitude_NN of_IN quality_NN issues_NNS
        to_TO be_VB addressed_VBN :_: complex_JJ care_NN is_VBZ typically_RB uncoordinated_JJ ,_,
        information_NN is_VBZ often_RB not_RB available_JJ to_TO those_DT who_WP need_VBP it_PRP
        when_WRB it_PRP is_VBZ needed_VBN ,_, and_CC as_IN a_DT result_NN patients_NNS often_RB do_VBP not_RB
        get_VB care_NN they_PRP need_VBP ,_, or_CC alternatively_RB do_VBP get_VB care_NN they_PRP do_VBP
        not_RB need_VB ._. A_DT common_JJ theme_NN underlying_VBG many_JJ of_IN these_DT quality_NN
        issues_NNS has_VBZ been_VBN under-investment_JJ in_IN information_NN technology_NN
        in_IN healthcare_NN ._.
      
      
        Discussion_NNP
        
          Information_NN technology_NN in_IN healthcare_NN today_NN
          Payment_NN issues_NNS ,_, rather_RB than_IN clinical_JJ needs_NNS ,_, have_VBP
          driven_VBN most_JJS investment_NN in_IN IT_PRP in_IN healthcare_NN ._. Thus_RB ,_, billing_NN
          systems_NNS are_VBP generally_RB much_RB better_JJR than_IN the_DT clinical_JJ
          systems_NNS ._. Furthermore_RB ,_, while_IN the_DT exact_JJ figure_NN varies_VBZ
          depending_VBG upon_IN the_DT survey_NN ,_, healthcare_NN has_VBZ invested_VBN at_IN
          least_JJS 50_CD %_NN less_JJR of_IN its_PRP$ gross_JJ revenues_NNS in_IN information_NN
          technology_NN than_IN other_JJ information-intensive_JJ industries_NNS
          like_IN banking_NN [_NN 2_CD 3_CD 4_CD ]_NN ._. Furthermore_RB ,_, while_IN banking_NN has_VBZ
          international_JJ standards_NNS for_IN exchange_NN of_IN data_NNS ,_, medicine_NN
          does_VBZ not_RB ._. As_IN a_DT result_NN ,_, one_PRP can_MD go_VB to_TO an_DT automated_VBN teller_NN
          in_IN Tokyo_NNP or_CC Moscow_NNP and_CC withdraw_VB money_NN with_IN a_DT card_NN ,_, but_CC
          going_VBG to_TO a_DT healthcare_NN provider_NN in_IN one_CD of_IN these_DT locations_NNS
          with_IN a_DT serious_JJ medical_JJ issue_NN would_MD be_VB a_DT rather_RB different_JJ
          experience_NN ._.
          In_IN other_JJ industries_NNS ,_, companies_NNS have_VBP used_VBN excellent_JJ
          information_NN technology_NN as_IN a_DT competitive_JJ edge_NN ._. For_IN
          example_NN ,_, American_NNP Airlines_NNPS derived_VBD substantial_JJ benefit_NN
          from_IN its_PRP$ SABRE_NNP system_NN ,_, which_WDT made_VBD it_PRP easy_JJ to_TO determine_VB
          which_WDT flights_NNS were_VBD available_JJ ,_, and_CC to_TO make_VB reservations_NNS [_NN
          5_CD ]_NN ._. Similarly_RB ,_, Federal_NNP Express_NNP with_IN its_PRP$ tracking_VBG system_NN
          has_VBZ an_DT enviably_RB high_JJ level_NN of_IN reliability_NN ,_, which_WDT
          customers_NNS have_VBP perceived_VBN as_RB extremely_RB valuable_JJ [_NN 6_CD ]_NN
          ._.
          Few_JJ similar_JJ examples_NNS exist_VBP in_IN healthcare_NN today_NN ._. While_IN
          a_DT few_JJ organizations_NNS have_VBP what_WP are_VBP perceived_VBN as_IN
          "_'' best-of-breed_JJ "_'' information_NN systems_NNS (_( LDS_NNP Hospital_NNP and_CC
          Intermountain_NNP Health_NNP Care_NNP in_IN Salt_NNP Lake_NNP City_NNP ,_, Wishard_NNP
          Memorial_NNP Hospital_NNP and_CC its_PRP$ affiliated_VBN clinics_NNS in_IN
          Indianapolis_NNP ,_, and_CC Brigham_NNP and_CC Women_NNP 's_POS Hospital_NNP and_CC
          Partners_NNPS HealthCare_NNP System_NNP in_IN Boston_NNP ,_, MA_NNP )_) ,_, [_NN 7_CD 8_CD 9_CD ]_NN the_DT
          reliability_NN of_IN these_DT systems_NNS is_VBZ nothing_NN like_IN that_DT offered_VBN
          by_IN the_DT systems_NNS of_IN companies_NNS outside_IN of_IN healthcare_NN ,_, for_IN
          example_NN Federal_NNP Express_NNP [_NN 10_CD ]_NN ._. These_DT organizations_NNS all_DT
          have_VBP had_VBN good_JJ financial_JJ performance_NN ,_, which_WDT has_VBZ given_VBN them_PRP
          an_DT edge_NN in_IN their_PRP$ local_JJ markets_NNS ,_, though_IN their_PRP$ goal_NN has_VBZ not_RB
          been_VBN to_TO spread_VB ._. In_IN addition_NN ,_, all_DT their_PRP$ information_NN
          systems_NNS were_VBD "_'' home-grown_JJ ,_, "_'' and_CC disseminating_VBG them_PRP has_VBZ
          proved_VBN difficult_JJ even_RB to_TO small_JJ hospitals_NNS within_IN their_PRP$ own_JJ
          networks_NNS ._. An_DT exception_NN has_VBZ been_VBN the_DT Veteran_NNP 's_POS
          Administration_NNP information_NN system_NN ,_, which_WDT is_VBZ an_DT important_JJ
          model_NN of_IN integration_NN ._. Information_NN technology_NN that_IN results_NNS
          in_IN better_RBR clinical_JJ quality_NN has_VBZ not_RB played_VBN the_DT same_JJ role_NN
          it_PRP does_VBZ in_IN other_JJ industries_NNS for_IN several_JJ reasons_NNS ._. One_CD is_VBZ
          that_IN fee-for-service_JJ reimbursement_NN did_VBD not_RB reward_VB
          efficiency_NN ._. Another_DT is_VBZ that_DT care_NN delivery_NN is_VBZ so_RB granular_JJ ;_:
          much_JJ of_IN it_PRP is_VBZ delivered_VBN by_IN not-for-profit_JJ organizations_NNS
          and_CC there_EX are_VBP not_RB just_RB a_DT few_JJ dominant_JJ players_NNS as_IN in_IN other_JJ
          industries_NNS ._. Finally_RB ,_, in_IN this_DT unusual_JJ market_NN ,_, the_DT
          healthcare_NN IT_PRP vendors_NNS have_VBP had_VBN strong_JJ incentives_NNS to_TO
          retain_VB their_PRP$ customer_NN base_NN and_CC avoid_VB
          interoperability_NN ._.
          Nonetheless_RB ,_, excellent_JJ IT_PRP and_CC high-quality_JJ health_NN care_NN
          are_VBP closely_RB linked_VBN ._. All_DT of_IN the_DT healthcare_NN organizations_NNS
          mentioned_VBN above_IN are_VBP recognized_VBN as_IN quality_NN leaders_NNS due_JJ to_TO
          excellent_JJ clinical_JJ outcomes_NNS ,_, which_WDT have_VBP been_VBN achieved_VBN in_IN
          part_NN because_IN of_IN their_PRP$ information_NN systems_NNS ._. Furthermore_RB ,_,
          the_DT organizations_NNS '_POS information_NN systems_NNS have_VBP several_JJ
          common_JJ threads_NNS :_: all_DT provide_VBP near-immediate_JJ access_NN to_TO a_DT
          wide_JJ array_NN of_IN information_NN including_VBG nearly_RB all_DT clinical_JJ
          results_NNS ;_: they_PRP are_VBP highly_RB integrated_VBN ;_: they_PRP provide_VBP
          clinical_JJ decision_NN support_NN ;_: they_PRP have_VBP both_DT inpatient_NN and_CC
          outpatient_NN data_NNS with_IN differing_VBG views_NNS for_IN each_DT ;_: and_CC they_PRP
          facilitate_VBP measurement_NN ._.
          Building_VBG the_DT "_'' pyramid_NN "_'' of_IN clinical_JJ information_NN systems_NNS
          begins_VBZ with_IN a_DT master_NN patient_NN index_NN and_CC results_NNS retrieval_NN ._.
          These_DT building_NN blocks_NNS are_VBP necessary_JJ before_IN higher_JJR level_NN
          applications_NNS are_VBP introduced_VBN ._. One_CD especially_RB important_JJ
          higher-level_JJ application_NN is_VBZ computerized_VBN physician_NN order_NN
          entry_NN ,_, in_IN which_WDT providers_NNS write_VBP orders_NNS including_VBG
          prescriptions_NNS using_VBG computers_NNS [_NN 11_CD ]_NN ._. Computerization_NNP of_IN
          ordering_VBG is_VBZ important_JJ because_IN most_JJS actions_NNS in_IN health_NN care_NN
          follow_VBP an_DT order_NN ;_: computerizing_VBG this_DT process_NN allows_VBZ
          provision_NN of_IN real-time_JJ decision_NN support_NN to_TO providers_NNS ,_, for_IN
          example_NN implementation_NN of_IN guidelines_NNS and_CC critical_JJ
          pathways_NNS ._. Another_DT application_NN that_WDT is_VBZ extremely_RB important_JJ
          for_IN delivering_VBG decision_NN support_NN is_VBZ a_DT program_NN called_VBD an_DT
          event_NN monitor_NN ,_, which_WDT sits_VBZ over_IN a_DT database_NN and_CC can_MD provide_VB
          notification_NN when_WRB an_DT important_JJ event_NN is_VBZ found_VBN (_( for_IN
          example_NN ,_, a_DT markedly_RB elevated_VBD serum_NN sodium_NN level_NN )_) [_NN 12_CD ]_NN ._.
          Even_RB more_JJR challenging_VBG than_IN computerizing_VBG ordering_VBG or_CC
          building_VBG an_DT event_NN monitor_NN ,_, especially_RB in_IN the_DT inpatient_NN
          setting_VBG ,_, is_VBZ computerizing_VBG the_DT medical_JJ record_NN ,_, especially_RB
          capturing_VBG of_IN notes_NNS in_IN real_JJ time_NN ._. Outpatient_NNP electronic_JJ
          medical_JJ records_NNS ,_, in_IN contrast_NN ,_, are_VBP relatively_RB easier_JJR to_TO
          implement_VB and_CC many_JJ examples_NNS of_IN well-developed_JJ outpatient_NN
          records_NNS exist_VBP [_NN 13_CD ]_NN ._. Many_JJ benefits_NNS can_MD be_VB realized_VBN with_IN
          the_DT addition_NN of_IN each_DT of_IN these_DT building_NN blocks_NNS ._.
          Unfortunately_RB ,_, the_DT industry_NN norm_NN in_IN U_NNP ._. S_NNP ._. clinical_JJ
          information_NN systems_NNS includes_VBZ only_RB the_DT base_NN of_IN the_DT
          pyramid_NN ,_, if_IN that_DT ._. While_IN most_JJS hospitals_NNS now_RB do_VBP have_VBP both_DT a_DT
          master_NN patient_NN index_NN and_CC results_NNS retrieval_NN available_JJ for_IN
          some_DT tests_NNS for_IN individual_JJ patients_NNS who_WP had_VBD tests_NNS done_VBN at_IN
          a_DT specific_JJ institution_NN ,_, views_NNS across_IN institutions_NNS are_VBP
          rare_JJ ,_, and_CC many_JJ results_NNS are_VBP not_RB incorporated_VBN ._. Building_VBG a_DT
          master_NN patient_NN index_NN is_VBZ challenging_VBG in_IN the_DT U_NNP ._. S_NNP ._. because_IN
          of_IN the_DT absence_NN of_IN a_DT unique_JJ identifier_NN ,_, and_CC building_NN and_CC
          maintaining_VBG such_JJ an_DT index_NN is_VBZ laborious_JJ ._. Many_JJ lab_NN tests_NNS
          are_VBP performed_VBN at_IN "_'' outside_IN "_'' laboratories_NNS ,_, and_CC because_IN of_IN
          this_DT lack_NN of_IN integration_NN such_JJ results_NNS are_VBP generally_RB
          unavailable_JJ via_IN the_DT information_NN system_NN ,_, as_IN may_MD be_VB the_DT
          case_NN with_IN unusual_JJ tests_NNS like_IN electroencephalograms_NNS ._. While_IN
          images_NNS of_IN a_DT variety_NN of_IN types_NNS including_VBG radiographs_NNS and_CC
          electrocardiograms_NNS can_MD now_RB readily_RB be_VB displayed_VBN ,_, [_NN 14_CD ]_NN
          such_JJ images_NNS are_VBP typically_RB not_RB yet_RB accessible_JJ to_TO
          providers_NNS ._.
          More_RBR important_JJ ,_, most_JJS hospital_NN systems_NNS provide_VBP little_JJ
          or_CC no_DT clinical_JJ decision_NN support_NN to_TO providers_NNS ._. Clinical_NNP
          decision_NN support_NN takes_VBZ many_JJ forms_NNS -_: including_VBG passive_JJ
          display_NN of_IN information_NN such_JJ as_IN the_DT last_JJ digoxin_NN level_NN and_CC
          potassium_NN in_IN a_DT patient_NN receiving_VBG digoxin_NN ;_: reminders_NNS -_: for_IN
          example_NN ,_, that_IN a_DT mammogram_NN is_VBZ due_JJ ;_: alerts_VBZ -_: that_IN the_DT
          hematocrit_NN is_VBZ falling_VBG rapidly_RB or_CC that_IN the_DT patient_NN has_VBZ an_DT
          allergy_NN to_TO the_DT prescribed_VBN drug_NN ;_: and_CC guidelines_NNS -_:
          suggestions_NNS about_IN orders_NNS in_IN a_DT patient_NN with_IN a_DT suspected_VBN
          myocardial_NN infarction_NN ._. Asking_NNP providers_NNS to_TO deliver_VB
          today_NN 's_POS complex_JJ care_NN without_IN such_JJ assistance_NN is_VBZ like_IN
          asking_VBG a_DT commercial_JJ pilot_NN to_TO fly_VB with_IN no_DT instruments_NNS ,_,
          given_VBN the_DT vast_JJ array_NN of_IN information_NN and_CC knowledge_NN that_IN
          providers_NNS must_MD handle_VB ._. One_CD reason_NN that_IN such_JJ clinical_JJ
          decision_NN support_NN is_VBZ infrequently_RB delivered_VBN is_VBZ that_DT
          today_NN 's_POS subsystems_NNS -_: for_IN example_NN ,_, the_DT laboratory_NN and_CC
          pharmacy_NN systems_NNS -_: do_VBP not_RB have_VB good_JJ interfaces_NNS and_CC thus_RB
          cannot_NN readily_RB communicate_VB with_IN each_DT other_JJ ._. This_DT lack_NN of_IN
          communication_NN makes_VBZ extracting_VBG important_JJ information_NN and_CC
          providing_VBG clinical_JJ decision_NN support_NN vastly_RB more_RBR difficult_JJ
          than_IN it_PRP needs_VBZ to_TO be_VB [_NN 15_CD 16_CD ]_NN ._.
          Furthermore_RB ,_, the_DT inpatient_NN and_CC outpatient_NN systems_NNS in_IN
          most_JJS healthcare_NN systems_NNS are_VBP disconnected_VBN ._. Rarely_RB can_MD
          providers_NNS access_VB outpatient_NN medical_JJ information_NN from_IN the_DT
          inpatient_NN setting_VBG ,_, or_CC vice_NN versa_RB ._. Yet_RB this_DT information_NN is_VBZ
          absolutely_RB pivotal_JJ to_TO providing_VBG safe_JJ ,_, efficient_JJ medical_JJ
          care_NN ;_: after_IN all_DT ,_, a_DT patient_NN 's_POS allergies_NNS are_VBP the_DT same_JJ both_DT
          inside_IN and_CC outside_IN the_DT hospital_NN ._. Covering_NNP for_IN another_DT
          physician_NN 's_POS patient_NN panel_NN is_VBZ vastly_RB easier_JJR ,_, safer_JJR and_CC
          more_RBR efficient_JJ when_WRB their_PRP$ medical_JJ record_NN -_: especially_RB
          their_PRP$ problems_NNS ,_, medications_NNS ,_, and_CC test_NN results_NNS -_: can_MD be_VB
          instantly_RB accessed_JJ ._. Transfers_NNP from_IN acute_JJ care_NN to_TO
          long-term_JJ care_NN or_CC home-care_JJ are_VBP also_RB problematic_JJ ;_: often_RB
          little_JJ information_NN is_VBZ transferred_VBN with_IN the_DT patient_NN ._. In_IN
          general_JJ ,_, outpatient_NN care_NN is_VBZ much_RB more_RBR fragmented_JJ than_IN
          inpatient_NN care_NN ,_, and_CC would_MD likely_JJ benefit_VB even_RB more_JJR from_IN
          computerization_NN and_CC communication_NN of_IN information_NN than_IN
          inpatient_NN care_NN ._.
          The_DT lack_NN of_IN electronic_JJ information_NN also_RB limits_VBZ quality_NN
          reporting_NN ._. Most_JJS organizations_NNS report_VBP externally_RB for_IN both_DT
          inpatients_NNS and_CC outpatients_NNS using_VBG only_RB claims_VBZ data_NNS ,_, as_IN
          required_VBN by_IN state_NN and_CC federal_JJ agencies_NNS ;_: this_DT is_VBZ sometimes_RB
          supplemented_JJ by_IN chart_NN review_NN ._. These_DT claims_NNS data_NN lack_VBP
          clinical_JJ detail_NN ,_, so_IN that_IN reports_NNS on_IN Pap_NNP smear_NN rates_NNS do_VBP
          not_RB take_VB into_IN account_NN ,_, for_IN example_NN ,_, whether_IN a_DT woman_NN has_VBZ
          had_VBD a_DT hysterectomy_NN [_NN 17_CD ]_NN ._. Internally_NNP ,_, organizations_NNS
          generally_RB have_VBP information_NN that_WDT is_VBZ somewhat_RB better_JJR ,_,
          although_IN this_DT information_NN is_VBZ often_RB sharply_RB limited_JJ ._. For_IN
          example_NN ,_, organizations_NNS may_MD assess_VB the_DT rates_NNS at_IN which_WDT
          groups_NNS of_IN patients_NNS (_( e_SYM ._. g_SYM ._. with_IN congestive_JJ heart_NN failure_NN )_)
          are_VBP compliant_NN with_IN a_DT few_JJ guidelines_NNS using_VBG chart_NN
          review_NN ._.
        
        
          How_WRB quality_NN improvement_NN is_VBZ currently_RB done_VBN
          Quality_JJ improvement_NN in_IN healthcare_NN today_NN is_VBZ going_VBG on_IN at_IN
          many_JJ levels_NNS ,_, but_CC is_VBZ generally_RB poorly_RB coordinated_VBN ._.
          Organizations_NNP ,_, practices_NNS ,_, hospitals_NNS ,_, and_CC insurers_NNS all_DT
          have_VBP programs_NNS intended_VBN to_TO improve_VB quality_NN ,_, but_CC many_JJ of_IN
          these_DT programs_NNS overlap_VBP ,_, and_CC most_JJS are_VBP of_IN marginal_JJ
          impact_NN ._.
          While_IN the_DT science_NN of_IN quality_NN improvement_NN has_VBZ grown_VBN
          dramatically_RB in_IN recent_JJ years_NNS ,_, many_JJ relatively_RB ineffective_JJ
          approaches_NNS remain_VBP the_DT workhorses_NNS of_IN change_NN ,_, especially_RB
          with_IN regard_NN to_TO physician_NN behavior_NN ._. In_IN particular_JJ ,_,
          education_NN continues_VBZ to_TO be_VB a_DT mainstay_NN ,_, and_CC is_VBZ often_RB
          carried_VBN out_IN through_IN lectures_VBZ and_CC newsletters_NNS ._. While_IN this_DT
          kind_NN of_IN passive_JJ education_NN clearly_RB plays_VBZ some_DT role_NN ,_,
          studies_NNS repeatedly_RB demonstrate_VBP that_IN its_PRP$ effect_NN is_VBZ modest_JJ
          and_CC wanes_VBZ rapidly_RB when_WRB discontinued_VBN [_NN 18_CD ]_NN ._.
          The_DT other_JJ main_JJ strategies_NNS for_IN changing_VBG physician_NN
          behavior_NN include_VBP feedback_NN ,_, financial_JJ incentives_NNS ,_,
          rationing_VBG and_CC penalties_NNS [_NN 19_CD ]_NN ._. Feedback_NNP -_: when_WRB given_VBN at_IN
          all_DT -_: is_VBZ typically_RB aggregate_NN and_CC retrospective_NN ._. Sometimes_RB
          providers_NNS do_VBP get_VB lists_NNS of_IN patients_NNS who_WP are_VBP out_IN of_IN
          compliance_NN for_IN a_DT certain_JJ measure_NN such_JJ as_IN mammography_NN ,_, but_CC
          these_DT lists_NNS ,_, while_IN useful_JJ ,_, are_VBP often_RB inaccurate_JJ because_IN
          they_PRP are_VBP based_VBN on_IN claims_NNS data_NNS ,_, and_CC they_PRP cover_VBP only_RB a_DT tiny_JJ
          proportion_NN of_IN the_DT issues_NNS that_WDT might_MD be_VB addressed_VBN ._.
          Financial_JJ incentives_NNS (_( e_SYM ._. g_SYM ._. capitation_NN )_) and_CC rationing_VBG
          (_( e_SYM ._. g_SYM ._. formularies_NNS )_) clearly_RB work_NN ,_, but_CC are_VBP resented_VBD by_IN
          physicians_NNS ,_, and_CC can_MD be_VB hard_JJ to_TO implement_VB ._. Penalties_NNP
          create_VB even_RB more_JJR resentment_NN ,_, and_CC are_VBP generally_RB
          counterproductive_JJ ._.
          A_DT more_RBR effective_JJ approach_NN to_TO changing_VBG physician_NN
          behavior_NN appears_VBZ to_TO be_VB provision_NN of_IN real-time_JJ education_NN
          and_CC feedback_NN while_IN providers_NNS are_VBP delivering_VBG care_NN using_VBG
          clinical_JJ decision_NN support_NN ._. Such_JJ decision_NN support_NN improves_VBZ
          decision-making_NN and_CC adherence_NN to_TO guidelines_NNS ,_, [_NN 20_CD ]_NN and_CC
          is_VBZ generally_RB well-accepted_JJ by_IN providers_NNS ._. It_PRP is_VBZ most_RBS
          effective_JJ if_IN delivered_VBN in_IN concert_NN with_IN other_JJ behavior_NN
          changing_VBG approaches_NNS ,_, including_VBG education_NN and_CC
          retrospective_NN feedback_NN ._.
          Another_DT highly_RB effective_JJ approach_NN for_IN improving_VBG
          quality_NN is_VBZ to_TO use_VB industrial_JJ quality_NN improvement_NN
          techniques_NNS to_TO address_VB and_CC retool_NN specific_JJ processes_NNS ,_,
          generally_RB with_IN multidisciplinary_JJ teams_NNS [_NN 21_CD ]_NN ._. Many_JJ of_IN
          the_DT processes_NNS within_IN medicine_NN were_VBD never_RB consciously_RB
          designed_VBN ._. Judicious_NNP introduction_NN of_IN IT_PRP into_IN many_JJ of_IN these_DT
          processes_VBZ may_MD be_VB helpful_JJ ._.
        
        
          How_WRB quality_NN is_VBZ currently_RB measured_VBN
          Today_NN ,_, most_JJS quality_NN measurement_NN within_IN organizations_NNS
          is_VBZ done_VBN using_VBG claims_NNS data_NNS ,_, which_WDT lack_VBP clinical_JJ detail_NN ._.
          Cases_NNS are_VBP aggregated_JJ using_VBG diagnosis-related_JJ groups_NNS
          (_( DRGs_NNP )_) which_WDT are_VBP assigned_VBN post-hoc_JJ and_CC may_MD not_RB accurately_RB
          represent_VB patients_NNS '_POS clinical_JJ presentations_NNS ._. The_DT outcomes_NNS
          most_RBS frequently_RB assessed_VBN are_VBP mortality_NN ,_, length_NN of_IN stay_NN ,_,
          and_CC charges_NNS (_( though_IN increasingly_RB costs_VBZ are_VBP being_VBG measured_VBN
          as_RB well_RB )_) ._. For_IN most_JJS conditions_NNS ,_, mortality_NN is_VBZ sufficiently_RB
          low_JJ to_TO be_VB meaningless_JJ ,_, and_CC even_RB for_IN conditions_NNS with_IN
          higher_JJR mortality_NN organizations_NNS often_RB do_VBP not_RB perform_VB
          severity_NN adjustment_NN because_IN of_IN the_DT difficulty_NN of_IN doing_VBG
          so_RB ,_, although_IN increasingly_RB good_JJ adjusters_NNS are_VBP becoming_VBG
          available_JJ [_NN 22_CD ]_NN ._. Length_NNP of_IN stay_NN can_MD be_VB decreased_VBN with_IN
          enough_RB focus_VB and_CC effort_NN ,_, and_CC it_PRP is_VBZ useful_JJ for_IN cost_NN
          reduction_NN efforts_NNS ,_, but_CC is_VBZ hardly_RB a_DT comprehensive_JJ quality_NN
          measure_NN ._.
          The_DT variables_NNS most_RBS amenable_JJ to_TO change_VB are_VBP process_NN
          measures_NNS ,_, and_CC many_JJ have_VBP been_VBN associated_VBN with_IN improved_VBN
          long-term_JJ outcomes_NNS [_NN 23_CD 24_CD 25_CD ]_NN ._. Examples_NNS include_VBP
          door-to-needle_JJ time_NN in_IN patients_NNS with_IN suspected_VBN myocardial_NN
          infarction_NN ,_, use_NN of_IN appropriate_JJ antibiotics_NNS in_IN patients_NNS
          with_IN community-acquired_JJ pneumonia_NN ,_, and_CC use_NN of_IN
          beta-blockers_JJ in_IN patients_NNS with_IN cardiac_JJ ischemia_NN ._. However_RB ,_,
          such_JJ process_NN measures_NNS are_VBP difficult_JJ or_CC impossible_JJ to_TO
          extract_VB from_IN claims_NNS data_NNS ,_, and_CC costly_JJ chart_NN review_NN is_VBZ
          typically_RB needed_VBN in_IN today_NN 's_POS system_NN ._. As_IN a_DT result_NN ,_, most_JJS
          organizations_NNS measure_NN only_RB a_DT few_JJ of_IN these_DT at_IN one_CD time_NN ,_,
          because_IN of_IN the_DT high_JJ cost_NN of_IN doing_VBG so_RB ._. Moreover_RB ,_, for_IN
          complications_NNS or_CC adverse_JJ events_NNS ,_, the_DT standard_NN is_VBZ to_TO rely_VB
          on_IN self-report_JJ by_IN providers_NNS ,_, which_WDT dramatically_RB
          underestimates_NNS the_DT frequency_NN of_IN these_DT events_NNS [_NN 26_CD ]_NN ._.
          Even_RB among_IN institutions_NNS which_WDT are_VBP leaders_NNS in_IN quality_NN
          measurement_NN ,_, the_DT current_JJ state_NN of_IN the_DT art_NN is_VBZ to_TO compare_VB
          crude_NN outcomes_NNS by_IN condition_NN from_IN claims_NNS data_NNS ,_, typically_RB
          using_VBG resources_NNS such_JJ as_IN the_DT University_NNP Hospital_NNP
          Consortium_NNP database_NN which_WDT includes_VBZ information_NN like_IN
          length_NN of_IN stay_NN and_CC morbidity_NN and_CC mortality_NN data_NNS [_NN 27_CD ]_NN ._.
          Such_JJ comparisons_NNS can_MD be_VB useful_JJ and_CC result_NN in_IN
          identification_NN of_IN problems_NNS that_WDT can_MD be_VB addressed_VBN in_IN an_DT
          organization_NN (_( for_IN example_NN if_IN high_JJ mortality_NN is_VBZ identified_VBN
          in_IN patients_NNS with_IN community-acquired_JJ pneumonia_NN )_) ,_, but_CC these_DT
          comparisons_NNS often_RB aggregate_JJ disparate_JJ groups_NNS of_IN patients_NNS ,_,
          involve_VB long_JJ lag_NN times_NNS and_CC lack_NN clinical_JJ detail_NN ._. In_IN
          addition_NN ,_, the_DT data_NNS may_MD or_CC may_MD not_RB be_VB used_VBN by_IN those_DT
          actually_RB delivering_VBG care_NN ._.
          The_DT recent_JJ interest_NN in_IN quality_NN by_IN payors_NNS and_CC
          regulators_NNS has_VBZ resulted_VBN in_IN a_DT multitude_NN of_IN requests_NNS for_IN
          quality_NN data_NNS ,_, which_WDT is_VBZ overwhelming_VBG the_DT limited_JJ resources_NNS
          of_IN quality_NN managers_NNS in_IN most_JJS organizations_NNS ,_, especially_RB as_IN
          most_JJS call_NN for_IN process_NN data_NNS which_WDT organizations_NNS do_VBP not_RB
          have_VB at_IN hand_NN ._. Typically_RB ,_, healthcare_NN has_VBZ devoted_VBN a_DT tiny_JJ
          fraction_NN of_IN its_PRP$ overall_JJ revenues_NNS to_TO quality_NN measurement_NN
          and_CC management_NN ,_, so_IN that_IN it_PRP is_VBZ not_RB surprising_JJ that_IN there_EX
          is_VBZ little_JJ reserve_NN ._.
        
        
          The_DT evidence_NN on_IN quality_NN and_CC IT_PRP
          While_IN increasing_VBG the_DT use_NN of_IN IT_PRP in_IN healthcare_NN would_MD
          result_VB in_IN benefits_NNS in_IN several_JJ domains_NNS ,_, the_DT quality_NN
          benefits_NNS will_MD probably_RB be_VB some_DT of_IN the_DT largest_JJS ._. In_IN
          particular_JJ ,_, this_DT would_MD improve_VB the_DT likelihood_NN that_WDT
          processes_VBZ will_MD be_VB successful_JJ ,_, and_CC would_MD allow_VB delivery_NN of_IN
          evidence-based_JJ decision_NN support_NN to_TO providers_NNS ,_, narrowing_VBG
          the_DT gaps_NNS between_IN evidence_NN and_CC practice_NN ._.
          Many_JJ studies_NNS now_RB show_VBP that_DT computerization_NN of_IN
          reminders_NNS and_CC prevention_NN guidelines_NNS improves_VBZ adherence_NN [_NN
          28_CD ]_NN ._. Reminders_NNP are_VBP especially_RB important_JJ in_IN the_DT care_NN of_IN
          chronic_JJ conditions_NNS ,_, which_WDT represent_VBP a_DT large_JJ proportion_NN of_IN
          expenditures_NNS [_NN 29_CD ]_NN ._. Management_NNP of_IN these_DT conditions_NNS
          requires_VBZ tracking_VBG on_IN the_DT part_NN of_IN patients_NNS as_RB well_RB as_IN
          excellent_JJ communication_NN between_IN providers_NNS and_CC patients_NNS
          regarding_VBG tracking_VBG and_CC deviations_NNS ;_: this_DT will_MD be_VB made_VBN
          dramatically_RB easier_JJR with_IN IT_PRP ._.
          It_PRP will_MD also_RB be_VB possible_JJ to_TO improve_VB safety_NN in_IN a_DT
          variety_NN of_IN ways_NNS by_IN increasing_VBG the_DT use_NN of_IN IT_PRP ,_, [_NN 30_CD ]_NN
          including_VBG introducing_VBG checks_NNS for_IN problems_NNS ,_, highlighting_VBG
          and_CC communicating_VBG information_NN about_IN key_JJ abnormalities_NNS to_TO
          providers_NNS so_IN they_PRP receive_VBP a_DT rapid_JJ response_NN ,_, and_CC
          facilitating_VBG communication_NN between_IN providers_NNS ._.
          Communication_NNP between_IN patients_NNS and_CC providers_NNS is_VBZ also_RB
          vitally_RB important_JJ for_IN safety_NN ,_, especially_RB outside_IN the_DT
          hospital_NN ._. In_IN one_CD study_NN of_IN outpatient_NN adverse_JJ drug_NN events_NNS ,_,
          a_DT large_JJ proportion_NN of_IN events_NNS could_MD have_VB been_VBN prevented_VBN or_CC
          ameliorated_JJ with_IN better_JJR communication_NN between_IN patients_NNS
          and_CC providers_NNS [_NN 31_CD ]_NN ._.
          Compared_VBN to_TO direct_VB improvement_NN ,_, quality_NN measurement_NN is_VBZ
          even_RB more_RBR profoundly_RB affected_VBN when_WRB information_NN is_VBZ stored_VBN
          electronically_RB in_IN electronic_JJ medical_JJ records_NNS ,_, which_WDT are_VBP
          vastly_RB richer_JJR than_IN claims_NNS databases_NNS ._. It_PRP becomes_VBZ possible_JJ
          to_TO routinely_RB find_VB patients_NNS with_IN certain_JJ conditions_NNS ,_, to_TO
          ask_VB questions_NNS about_IN their_PRP$ recent_JJ laboratory_NN values_NNS ,_, and_CC
          even_RB to_TO go_VB through_IN their_PRP$ notes_NNS to_TO look_VB for_IN certain_JJ
          issues_NNS ,_, like_IN new_JJ problems_NNS [_NN 32_CD 33_CD ]_NN ._.
          Finally_RB ,_, electronic_JJ records_NNS can_MD be_VB linked_VBN with_IN public_JJ
          health_NN surveillance_NN ._. The_DT events_NNS of_IN September_NNP 11_CD
          underscore_VBP the_DT obvious_JJ need_VBP to_TO improve_VB these_DT links_NNS [_NN 34_CD ]_NN
          ._.
        
        
          The_DT financial_JJ case_NN for_IN IT_PRP and_CC quality_NN
          Overall_RB ,_, disappointingly_RB few_JJ studies_NNS have_VBP examined_VBN the_DT
          financial_JJ case_NN for_IN IT_PRP and_CC quality_NN ,_, and_CC doing_VBG so_RB is_VBZ
          methodologically_RB challenging_VBG ._. But_CC in_IN other_JJ industries_NNS ,_,
          investment_NN was_VBD made_VBN because_IN it_PRP made_VBD sense_NN ,_, and_CC not_RB
          because_IN of_IN randomized_JJ controlled_VBN trials_NNS ._.
          That_DT being_VBG said_VBN ,_, some_DT data_NNS are_VBP available_JJ ,_, although_IN
          most_JJS relate_VBP to_TO individual_JJ features_NNS or_CC applications_NNS ._. For_IN
          example_NN ,_, in_IN a_DT randomized_JJ controlled_VBN trial_NN Tierney_NNP et_CC al_NN ._.
          found_VBD that_DT use_NN of_IN computerized_JJ physician_NN order_NN entry_NN as_IN
          compared_VBN to_TO paper_NN ordering_VBG resulted_VBN in_IN 12_CD ._. 7_CD %_NN lower_JJR
          charges_NNS (_( p_NN =_SYM ._. 02_CD )_) and_CC 13_CD ._. 1_LS %_NN lower_JJR costs_NNS (_( p_NN =_SYM 0_CD ._. 02_CD )_) [_NN 7_CD ]_NN ._.
          They_PRP believed_VBD that_IN many_JJ of_IN the_DT benefits_NNS were_VBD seen_VBN because_IN
          of_IN delivery_NN of_IN computerized_JJ decision_NN support_NN at_IN the_DT time_NN
          of_IN ordering_VBG ._. Our_PRP$ group_NN found_VBD that_DT implementation_NN of_IN
          computerized_JJ physician_NN order_NN entry_NN resulted_VBD in_IN a_DT 55_CD %_NN
          decrease_NN in_IN the_DT serious_JJ medication_NN error_NN rate_NN [_NN 35_CD ]_NN
          ._.
          In_IN other_JJ non-clinical_JJ domains_NNS ,_, for_IN example_NN in_IN the_DT
          evaluation_NN of_IN electronic_JJ claims_NNS processing_NN vs_NNS ._. manual_JJ
          processing_NN ,_, electronic_JJ processing_NN will_MD clearly_RB have_VB
          benefits_NNS ,_, although_IN relatively_RB few_JJ data_NNS are_VBP available_JJ ._.
          Similarly_RB ,_, changes_NNS that_WDT result_NN in_IN greater_JJR efficiencies_NNS in_IN
          patient_NN and_CC specimen_NN movement_NN ,_, as_RB well_RB as_IN decreased_VBN work_NN
          for_IN staff_NN ,_, will_MD likely_RB be_VB highly_RB beneficial_JJ ,_, although_IN the_DT
          impact_NN is_VBZ difficult_JJ to_TO measure_VB ._.
          To_TO assess_VB the_DT overall_JJ costs_NNS and_CC benefits_NNS of_IN an_DT
          electronic_JJ medical_JJ record_NN system_NN ,_, Kian_NNP [_NN 36_CD ]_NN constructed_VBN
          a_DT cost-benefit_JJ model_NN for_IN a_DT hypothetical_JJ computer-based_JJ
          patient_NN record_NN system_NN planned_VBN for_IN the_DT M_NNP ._. D_NNP ._. Anderson_NNP
          Cancer_NNP Center_NNP ,_, and_CC predicted_VBD that_IN over_IN a_DT 10_CD -_: year_NN period_NN ,_,
          the_DT total_JJ costs_NNS would_MD be_VB $_$ 54_CD ._. 5_LS million_CD and_CC the_DT total_JJ
          benefits_NNS would_MD be_VB $_$ 129_CD ._. 7_CD million_CD ._. In_IN the_DT ambulatory_JJ
          setting_NN ,_, Renner_NNP performed_VBD a_DT study_NN of_IN a_DT 40_CD -_: physician_NN
          ambulatory_JJ care_NN medical_JJ group_NN and_CC estimated_VBD a_DT net_JJ present_JJ
          value_NN for_IN the_DT EMR_NNP system_NN of_IN $_$ 279_CD ,_, 670_CD [_NN 37_CD ]_NN ._.
          Less_RBR direct_JJ evidence_NN comes_VBZ from_IN a_DT recent_JJ study_NN
          suggesting_VBG that_IN organizations_NNS that_WDT invest_VBP more_JJR in_IN IT_PRP are_VBP
          more_RBR efficient_JJ [_NN 38_CD ]_NN ._. The_DT "_'' most_RBS wired_VBN "_'' hospitals_NNS had_VBD
          lower_JJR median_JJ expenses_NNS per_IN discharge_NN and_CC greater_JJR
          productivity_NN ,_, as_IN measured_VBN by_IN full-time_JJ equivalent_NN staff_NN
          (_( FTE_NNP )_) per_IN adjusted_VBN occupied_JJ bed_NN ,_, paid_VBN hours_NNS per_IN adjusted_VBN
          discharge_NN ,_, and_CC net_JJ patient_NN revenue_NN per_IN FTE_NNP ._. However_RB ,_,
          differences_NNS in_IN clinical_JJ outcomes_NNS were_VBD less_RBR clear_JJ :_: in_IN
          cardiovascular_JJ disease_NN and_CC obstetrics_NNS ,_, the_DT "_'' most_RBS wired_VBN "_''
          appeared_VBD to_TO perform_VB better_JJR ,_, but_CC were_VBD similar_JJ with_IN the_DT
          nation_NN 's_POS average_NN across_IN the_DT other_JJ 4_CD categories_NNS
          studied_VBN ._.
          Taken_VBN together_RB ,_, these_DT data_NNS suggest_VBP that_IN benefits_NNS can_MD
          be_VB demonstrated_VBN for_IN specific_JJ applications_NNS and_CC domains_NNS ._.
          However_RB ,_, many_JJ benefits_NNS will_MD take_VB time_NN to_TO be_VB realized_VBN ,_, and_CC
          may_MD accrue_VB across_IN a_DT sufficiently_RB broad_JJ range_NN of_IN areas_NNS
          that_IN it_PRP will_MD be_VB hard_JJ to_TO attribute_VB them_PRP directly_RB to_TO
          changes_NNS in_IN IT_PRP ._. Nonetheless_RB ,_, the_DT aggregate_JJ data_NN do_VBP suggest_VBP
          that_IN better_JJR IT_PRP in_IN healthcare_NN ,_, as_IN in_IN other_JJ industries_NNS ,_, is_VBZ
          associated_VBN with_IN greater_JJR efficiency_NN and_CC will_MD be_VB associated_VBN
          with_IN higher_JJR quality_NN as_RB well_RB ._.
        
        
          How_WRB recent_JJ changes_NNS including_VBG the_DT internet_NN affect_VBP
          the_DT equation_NN
          Several_JJ recent_JJ changes_NNS in_IN information_NN technology_NN make_NN
          rapid_JJ adoption_NN of_IN IT_PRP in_IN healthcare_NN especially_RB attractive_JJ ._.
          One_CD is_VBZ that_IN the_DT cost_NN of_IN computer_NN processing_NN continues_VBZ to_TO
          decline_VB ._. Another_DT more_RBR profound_JJ change_NN is_VBZ the_DT Internet_NN ,_,
          which_WDT essentially_RB represents_VBZ an_DT inexpensive_JJ ,_, broadly_RB
          distributed_VBN platform_NN that_WDT is_VBZ ubiquitously_RB available_JJ ,_, even_RB
          to_TO small_JJ or_CC geographically_RB remote_JJ sites_NNS ._. This_DT makes_VBZ it_PRP
          possible_JJ to_TO distribute_VB information_NN and_CC knowledge_NN at_IN very_RB
          low_JJ costs_NNS ._. This_DT will_MD affect_VB the_DT delivery_NN of_IN software_NN and_CC
          data_NNS for_IN quality_NN improvement_NN ,_, measurement_NN ,_, and_CC research_NN ._.
          For_IN example_NN ,_, in_IN one_CD large_JJ on-going_JJ study_NN ,_, investigators_NNS
          have_VBP set_VBN up_RP an_DT approach_NN in_IN which_WDT identifiable_JJ data_NNS remain_VBP
          local_JJ due_NN to_TO privacy_NN issues_NNS ,_, but_CC analyses_NNS are_VBP conducted_VBN
          centrally_RB using_VBG deidentified_JJ data_NNS ._. Mirrored_NNP code_NN is_VBZ sent_VBN
          out_IN to_TO individual_JJ sites_NNS via_IN the_DT internet_NN to_TO minimize_VB
          programming_NN burden_NN [_NN 39_CD ]_NN ._. Finally_RB ,_, handheld_JJ devices_NNS
          will_MD increasingly_RB allow_VB extension_NN of_IN desktop_NN systems_NNS and_CC
          will_MD be_VB used_VBN for_IN many_JJ routine_JJ tasks_NNS such_JJ as_IN capturing_VBG
          vital_JJ signs_NNS or_CC administering_VBG medications_NNS ._.
        
        
          Vision_NNP of_IN quality_NN improvement_NN
          The_DT high-quality_JJ health_NN care_NN information_NN systems_NNS of_IN
          the_DT future_NN will_MD be_VB vastly_RB different_JJ from_IN those_DT of_IN today_NN ._.
          Longitudinal_NNP medical_JJ records_NNS will_MD allow_VB tracking_NN of_IN
          patients_NNS '_POS conditions_NNS and_CC medications_NNS so_IN that_IN providers_NNS in_IN
          emergency_NN rooms_NNS and_CC hospitals_NNS will_MD have_VB detailed_JJ
          information_NN at_IN their_PRP$ fingertips_NNS ._. Clinicians_NNP will_MD document_VB
          using_VBG structured_VBN tools_NNS that_WDT allow_VBP capture_NN of_IN patient_NN
          symptoms_NNS ,_, clinical_JJ findings_NNS ,_, and_CC the_DT physician_NN 's_POS
          assessment_NN ._. The_DT interdisciplinary_JJ teams_NNS that_WDT manage_VBP
          patients_NNS with_IN chronic_JJ conditions_NNS will_MD be_VB able_JJ to_TO track_VB
          their_PRP$ panels_NNS ,_, and_CC seamlessly_RB exchange_VB information_NN ._. When_WRB
          patients_NNS are_VBP admitted_VBN to_TO a_DT hospital_NN ,_, they_PRP will_MD be_VB tracked_VBN
          from_IN the_DT instant_JJ they_PRP enter_VBP the_DT hospital_NN until_IN they_PRP
          leave_VBP ._. Because_IN diagnoses_NNS will_MD be_VB entered_VBN early_JJ ,_,
          guidelines_NNS will_MD be_VB made_VBN available_JJ to_TO providers_NNS ._. It_PRP will_MD
          be_VB easy_JJ to_TO see_VB where_WRB a_DT patient_NN physically_RB is_VBZ at_IN any_DT time_NN ,_,
          where_WRB they_PRP are_VBP in_IN their_PRP$ hospital_NN course_NN ,_, what_WP their_PRP$
          treatment_NN is_VBZ ,_, and_CC whether_IN guidelines_NNS are_VBP being_VBG followed_VBN ._.
          In_IN one_CD controlled_VBN trial_NN simply_RB posting_VBG the_DT expected_VBN
          length_NN of_IN stay_NN for_IN patients_NNS by_IN condition_NN resulted_VBD in_IN a_DT
          decreased_VBN length_NN of_IN stay_NN ,_, [_NN 40_CD ]_NN and_CC this_DT sort_NN of_IN thing_NN
          will_MD be_VB done_VBN routinely_RB in_IN a_DT variety_NN of_IN clinical_JJ
          situations_NNS ._. Both_DT patients_NNS and_CC providers_NNS will_MD have_VB a_DT
          better_JJR sense_NN of_IN what_WP will_MD occur_VB and_CC when_WRB ,_, and_CC this_DT will_MD
          result_VB in_IN higher_JJR satisfaction_NN in_IN both_DT groups_NNS ._. When_WRB
          patients_NNS leave_VBP the_DT hospital_NN ,_, their_PRP$ information_NN will_MD go_VB
          with_IN them_PRP to_TO the_DT team_NN responsible_JJ for_IN post-hospital_JJ care_NN ._.
          This_DT system_NN will_MD include_VB safety_NN nets_NNS that_WDT are_VBP not_RB present_JJ
          today_NN (_( so_IN that_IN if_IN a_DT patient_NN does_VBZ not_RB arrive_VB in_IN clinic_NN
          after_IN a_DT hospitalization_NN ,_, someone_NN will_MD go_VB looking_VBG for_IN
          them_PRP )_) ._. Such_JJ nets_NNS are_VBP conspicuously_RB absent_JJ in_IN today_NN 's_POS
          system_NN ._.
          Much_JJ of_IN the_DT quality_NN improvement_NN that_WDT is_VBZ done_VBN will_MD
          revolve_VB around_IN refinement_NN of_IN specific_JJ processes_NNS ,_, for_IN
          example_NN the_DT process_NN of_IN getting_VBG a_DT patient_NN through_IN a_DT
          cardiac_JJ catheterization_NN ,_, the_DT medication_NN process_NN ,_, or_CC the_DT
          process_NN of_IN dealing_VBG with_IN diabetic_JJ outpatients_NNS with_IN poor_JJ
          glycemic_JJ control_NN ._. Teams_NNS will_MD have_VB not_RB only_RB the_DT
          information_NN they_PRP now_RB have_VBP ,_, but_CC also_RB detailed_JJ time_NN data_NNS ,_,
          information_NN about_IN how_WRB often_RB processes_VBZ fail_VB or_CC are_VBP
          delayed_VBN ,_, and_CC information_NN about_IN the_DT outcomes_NNS of_IN processes_NNS ._.
          They_PRP will_MD also_RB have_VB better_JJR outcome_NN data_NNS ,_, which_WDT patients_NNS
          will_MD provide_VB ._.
          Patients_NNS will_MD be_VB a_DT much_RB more_RBR active_JJ part_NN of_IN care_NN ._. They_PRP
          will_MD have_VB much_RB more_JJR information_NN and_CC control_NN ,_, and_CC will_MD
          interact_NN with_IN the_DT healthcare_NN system_NN outside_IN of_IN visits_NNS
          much_RB more_JJR than_IN is_VBZ usual_JJ today_NN ._. Self-management_NNP will_MD be_VB
          the_DT norm_NN for_IN chronic_JJ conditions_NNS [_NN 41_CD ]_NN ._. All_DT of_IN this_DT will_MD
          be_VB facilitated_JJ by_IN IT_PRP :_: by_IN patient_NN websites_NNS that_WDT allow_VBP them_PRP
          to_TO interact_NN with_IN their_PRP$ providers_NNS ,_, by_IN integrated_VBN networks_NNS
          within_IN healthcare_NN organizations_NNS ,_, and_CC by_IN electronic_JJ
          records_NNS that_WDT are_VBP the_DT backbone_NN for_IN these_DT functions_NNS ._. Thus_RB ,_,
          diabetics_NNS will_MD enter_VB glucose_NN and_CC blood_NN pressure_NN results_NNS
          on_IN their_PRP$ website_NN ,_, receive_VB suggestions_NNS regarding_VBG changes_NNS
          in_IN management_NN to_TO improve_VB their_PRP$ control_NN ,_, and_CC be_VB notified_VBN
          when_WRB they_PRP are_VBP overdue_JJ for_IN preventive_JJ measures_NNS like_IN eye_NN or_CC
          foot_NN exams_NNS ._.
        
        
          Vision_NNP of_IN quality_NN measurement_NN
          Quality_JJ measurement_NN depends_VBZ even_RB more_RBR on_IN use_NN and_CC
          integration_NN of_IN information_NN technology_NN than_IN does_VBZ quality_NN
          improvement_NN ._. In_IN the_DT future_NN ,_, it_PRP will_MD become_VB routine_JJ to_TO
          measure_VB quality_NN on_IN an_DT on-going_JJ basis_NN for_IN many_JJ conditions_NNS
          and_CC processes_VBZ ,_, and_CC this_DT measurement_NN will_MD take_VB place_NN as_IN
          care_NN is_VBZ provided_VBN and_CC be_VB integrated_VBN into_IN the_DT fabric_NN of_IN
          routine_JJ care_NN ._. For_IN example_NN for_IN a_DT patient_NN with_IN a_DT myocardial_NN
          infarction_NN ,_, the_DT time_NN they_PRP are_VBP first_RB seen_VBN by_IN emergency_NN
          technicians_NNS ,_, the_DT time_NN they_PRP arrive_VBP at_IN the_DT emergency_NN
          department_NN ,_, and_CC the_DT time_NN they_PRP get_VBP to_TO the_DT catheterization_NN
          laboratory_NN will_MD all_DT be_VBP routinely_RB logged_VBN ._. In_IN addition_NN ,_, the_DT
          time_NN when_WRB many_JJ key_JJ medications_NNS were_VBD given_VBN will_MD be_VB
          recorded_VBN ,_, as_IN will_MD a_DT number_NN of_IN key_JJ historical_JJ and_CC physical_JJ
          findings_NNS ._. Nurses_NNP and_CC physicians_NNS will_MD chart_VB using_VBG tools_NNS
          that_WDT capture_NN key_JJ data_NNS in_IN structured_VBN format_NN ._. This_DT will_MD
          facilitate_VB both_DT clinical_JJ care_NN and_CC research_NN ,_, so_IN that_RB ,_, for_IN
          example_NN ,_, patients_NNS with_IN cardiogenic_JJ shock_NN can_MD be_VB rapidly_RB
          identified_VBN and_CC offered_VBD the_DT opportunity_NN to_TO participate_VB in_IN
          controlled_VBN trials_NNS ._.
          Gathering_NNP these_DT types_NNS of_IN data_NNS will_MD then_RB dramatically_RB
          facilitate_VB process_NN improvement_NN ,_, because_IN it_PRP will_MD be_VB
          possible_JJ to_TO address_VB issues_NNS of_IN variation_NN ,_, and_CC to_TO determine_VB
          where_WRB delays_NNS and_CC suboptimal_NN outcomes_NNS are_VBP occurring_VBG ._.
          Risk-adjusted_NNP comparisons_NNS within_IN and_CC among_IN institutions_NNS
          will_MD be_VB possible_JJ ,_, which_WDT will_MD allow_VB overall_JJ improvement_NN
          like_IN that_DT which_WDT has_VBZ been_VBN achieved_VBN by_IN a_DT few_JJ isolated_VBN
          groups_NNS such_JJ as_IN the_DT Northern_NNP New_NNP England_NNP Cardiovascular_NNP
          Collaborative_NNP [_NN 42_CD ]_NN ._.
        
        
          Barriers_NNP to_TO change_VB
          Perhaps_RB the_DT most_RBS difficult_JJ and_CC problematic_JJ barrier_NN to_TO
          adoption_NN of_IN quality-related_JJ IT_PRP is_VBZ that_IN incentives_NNS for_IN
          adopting_VBG such_JJ changes_NNS are_VBP lacking_VBG under_IN the_DT current_JJ
          reimbursement_NN system_NN ._. For_IN example_NN ,_, under_IN fee-for-service_JJ
          reimbursement_NN there_EX is_VBZ no_DT financial_JJ incentive_NN for_IN
          hospitals_NNS to_TO reduce_VB adverse_JJ event_NN rates_NNS ._. Even_RB under_IN
          prospective_JJ or_CC capitated_JJ reimbursement_NN ,_, justifying_VBG
          investment_NN in_IN technology_NN that_WDT will_MD result_VB in_IN longer-term_JJ
          benefit_NN may_MD be_VB hard_RB for_IN capital-strapped_JJ organizations_NNS ._.
          In_IN contrast_NN ,_, technologies_NNS like_IN magnetic_JJ resonance_NN imaging_NN
          scanners_NNS result_VBP in_IN billable_JJ services_NNS and_CC hospitals_NNS have_VBP
          had_VBN no_DT trouble_NN making_VBG these_DT investments_NNS ._.
          An_DT additional_JJ issue_NN with_IN the_DT current_JJ reimbursement_NN
          system_NN is_VBZ that_IN providers_NNS are_VBP not_RB reimbursed_VBN for_IN care_NN that_WDT
          occurs_VBZ outside_IN encounters_NNS ._. Reform_NNP of_IN the_DT payment_NN system_NN
          to_TO reward_VB such_JJ care_NN is_VBZ badly_RB needed_VBN [_NN 1_CD ]_NN ._. Also_RB ,_, support_NN
          for_IN collecting_VBG quality_NN measurement_NN data_NNS is_VBZ necessary_JJ [_NN 43_CD
          ]_NN ._.
          Legal_JJ issues_NNS relating_VBG to_TO this_DT area_NN also_RB represent_VB an_DT
          important_JJ barrier_NN ._. For_IN example_NN ,_, the_DT Stark_NNP laws_NNS make_VBP
          difficult_JJ some_DT collaborations_NNS that_WDT would_MD be_VB beneficial_JJ ,_,
          for_IN example_NN for_IN an_DT integrated_VBN delivery_NN system_NN to_TO support_VB
          implementation_NN of_IN electronic_JJ records_NNS in_IN affiliated_VBN
          physician_NN offices_NNS ._.
          Another_DT problem_NN has_VBZ been_VBN that_IN information_NN systems_NNS are_VBP
          highly_RB complex_JJ ,_, and_CC provide_VB uncertain_JJ return_NN on_IN
          investment_NN ._. Because_IN of_IN the_DT complexity_NN of_IN information_NN
          systems_NNS ,_, an_DT organization_NN will_MD generally_RB be_VB best_JJS off_RP
          developing_VBG a_DT long-term_JJ relationship_NN with_IN one_CD or_CC a_DT few_JJ
          vendors_NNS because_IN of_IN issues_NNS relating_VBG to_TO connectivity_NN ._.
          Because_IN of_IN this_DT ,_, the_DT approach_NN of_IN vendors_NNS in_IN this_DT domain_NN
          has_VBZ been_VBN to_TO develop_VB non-standard_JJ software_NN ,_, and_CC to_TO hold_VB
          tightly_RB to_TO its_PRP$ client_NN base_NN ._. Making_VBG a_DT transition_NN from_IN one_CD
          vendor_NN to_TO another_DT today_NN is_VBZ difficult_JJ because_IN of_IN the_DT lack_NN
          of_IN standards_NNS ._.
          A_DT further_JJ key_JJ issue_NN is_VBZ the_DT wide_JJ array_NN of_IN healthcare_NN
          organizations_NNS and_CC the_DT highly_RB disparate_JJ nature_NN of_IN groups_NNS ,_,
          ranging_VBG from_IN solo_NN practitioners_NNS and_CC small_JJ hospitals_NNS to_TO
          large_JJ hospitals_NNS and_CC large_RB integrated_VBN delivery_NN systems_NNS ._. A_DT
          solution_NN that_WDT is_VBZ effective_JJ in_IN a_DT large_JJ hospital_NN may_MD not_RB
          work_VB in_IN a_DT much_RB smaller_JJR one_CD ._. However_RB ,_, the_DT internet_NN should_MD
          make_VB it_PRP possible_JJ to_TO deliver_VB applications_NNS to_TO a_DT wide_JJ array_NN
          of_IN even_RB geographically_RB remote_JJ sites_NNS at_IN low_JJ cost_NN ._.
          A_DT further_JJ barrier_NN relates_VBZ to_TO privacy_NN ,_, confidentiality_NN
          and_CC security_NN of_IN health_NN information_NN ._. Today_NN 's_POS laws_NNS
          regarding_VBG these_DT issues_NNS relate_VBP mainly_RB to_TO a_DT paper_NN world_NN and_CC
          are_VBP inadequate_JJ [_NN 44_CD ]_NN ._. While_IN the_DT Health_NNP Insurance_NNP
          Portability_NNP and_CC Accessibility_NNP Act_NNP (_( HIPAA_NNP )_) begins_VBZ to_TO
          address_VB some_DT of_IN the_DT relevant_JJ issues_NNS ,_, much_JJ remains_VBZ to_TO be_VB
          done_VBN ._. Thus_RB ,_, while_IN additional_JJ legislation_NN is_VBZ needed_VBN ,_, it_PRP
          must_MD be_VB crafted_VBN in_IN ways_NNS that_WDT make_VBP a_DT revolution_NN in_IN
          healthcare_NN information_NN possible_JJ ,_, and_CC do_VBP not_RB paralyze_NN this_DT
          revolution_NN [_NN 45_CD ]_NN ._. Specifically_RB ,_, it_PRP might_MD become_VB
          extremely_RB difficult_JJ to_TO do_VB clinical_JJ research_NN if_IN new_JJ
          legislation_NN is_VBZ too_RB restrictive_JJ ;_: to_TO address_VB many_JJ issues_NNS ,_,
          access_NN to_TO large_JJ populations_NNS is_VBZ critical_JJ ._. Technically_RB ,_, it_PRP
          is_VBZ feasible_JJ today_NN to_TO ensure_VB data_NNS safety_NN ,_, but_CC much_JJ work_NN is_VBZ
          needed_VBN in_IN this_DT domain_NN to_TO develop_VB laws_NNS and_CC regulation_NN that_IN
          adequately_RB balance_NN privacy_NN concerns_NNS with_IN the_DT quality_NN
          benefits_NNS that_WDT may_MD be_VB realized_VBN through_IN use_NN of_IN health_NN
          information_NN [_NN 46_CD ]_NN ._.
        
        
          Policy_NNP Implications_NNP
          
            Standards_NNP
            An_DT absolutely_RB pivotal_JJ early_JJ step_NN is_VBZ establishment_NN of_IN
            national_JJ standards_NNS for_IN key_JJ medical_JJ domains_NNS ,_, including_VBG
            messaging_VBG ,_, problems_NNS and_CC conditions_NNS ,_, laboratory_NN and_CC
            radiology_NN data_NNS ,_, medication_NN data_NNS ,_, and_CC pathology_NN results_NNS
            [_NN 47_CD ]_NN ._. Until_IN recently_RB ,_, adequate_JJ standards_NNS were_VBD not_RB
            available_JJ ,_, but_CC that_DT has_VBZ rapidly_RB changed_VBN ,_, and_CC a_DT number_NN
            of_IN other_JJ nations_NNS including_VBG England_NNP have_VBP taken_VBN the_DT
            approach_NN of_IN establishing_VBG national_JJ standards_NNS ,_, requiring_VBG
            that_IN if_IN vendors_NNS want_VBP to_TO participate_VB in_IN delivery_NN of_IN
            information_NN technology_NN ,_, they_PRP must_MD adhere_VB to_TO these_DT
            standards_NNS [_NN 48_CD ]_NN ._. This_DT makes_VBZ it_PRP possible_JJ for_IN a_DT market_NN
            to_TO continue_VB to_TO function_VB ,_, but_CC under_IN certain_JJ rules_NNS
            (_( analogous_JJ to_TO setting_VBG up_RP a_DT rule_NN for_IN a_DT discussion_NN that_DT
            everyone_NN can_MD talk_VB as_RB long_RB as_IN they_PRP speak_VBP English_NNP )_) ._.
          
          
            Incentives_NNP
            Probably_RB the_DT most_RBS important_JJ step_NN in_IN achieving_VBG this_DT
            vision_NN is_VBZ to_TO establish_VB incentives_NNS that_WDT make_VBP it_PRP
            attractive_JJ for_IN organizations_NNS to_TO invest_VB in_IN information_NN
            technology_NN ._. While_IN non-financial_JJ incentives_NNS will_MD play_VB
            some_DT role_NN (_( for_IN example_NN ,_, giving_VBG organizations_NNS special_JJ
            recognition_NN if_IN they_PRP implement_VB certain_JJ processes_NNS ,_, or_CC can_MD
            demonstrate_VB they_PRP have_VB excellent_JJ outcomes_NNS )_) ,_, financial_JJ
            incentives_NNS are_VBP likely_JJ to_TO be_VB more_RBR important_JJ for_IN
            achieving_VBG major_JJ change_NN ._. These_DT could_MD take_VB the_DT form_NN of_IN
            grants_NNS ,_, tax_NN credits_NNS or_CC low-interest_JJ loans_NNS to_TO
            organizations_NNS making_VBG major_JJ investments_NNS in_IN areas_NNS that_WDT
            have_VBP been_VBN demonstrated_VBN to_TO improve_VB care_NN ._. Another_DT option_NN
            that_WDT has_VBZ been_VBN suggested_VBN is_VBZ differential_NN payment_NN scales_NNS
            depending_VBG on_IN whether_IN or_CC not_RB a_DT technology_NN such_JJ as_IN
            computerized_JJ physician_NN order_NN entry_NN is_VBZ in_IN use_NN or_CC not_RB ,_,
            which_WDT has_VBZ been_VBN recommended_VBN by_IN the_DT Medicare_NNP Patient_NNP
            Advisory_NNP Commission_NNP [_NN 49_CD ]_NN ._. Examples_NNS of_IN the_DT type_NN of_IN
            financial_JJ incentives_NNS already_RB in_IN play_NN that_WDT could_MD provide_VB
            good_JJ starts_NNS include_VBP legislation_NN already_RB under_IN
            consideration_NN by_IN Congress_NNP ._. The_DT Medication_NNP Errors_NNP
            Reduction_NNP Act_NNP of_IN 2001_CD ,_, introduced_VBN to_TO the_DT Senate_NNP by_IN
            Senators_NNP Graham_NNP and_CC Snowe_NNP ,_, has_VBZ been_VBN introduced_VBN also_RB in_IN
            the_DT House_NNP by_IN Representatives_NNPS Houghton_NNP and_CC Thurman_NNP [_NN 50_CD
            ]_NN ._. This_DT proposal_NN would_MD provide_VB nearly_RB $_$ 1_CD billion_CD of_IN
            funding_NN over_IN 10_CD years_NNS for_IN hospitals_NNS and_CC skilled_JJ nursing_NN
            facilities_NNS to_TO purchase_VB information_NN technology_NN to_TO
            improve_VB medication_NN safety_NN ._. Another_DT bill_NN ,_, the_DT Health_NNP
            Information_NNP and_CC Quality_NNP Improvement_NNP Act_NNP of_IN 2001_CD ,_, would_MD
            provide_VB $_$ 420_CD million_CD to_TO help_VB hospitals_NNS develop_VB and_CC use_VB
            information_NN technology_NN that_WDT can_MD reduce_VB the_DT frequency_NN of_IN
            medical_JJ errors_NNS [_NN 51_CD ]_NN ._. However_RB such_JJ support_NN would_MD not_RB
            be_VB sufficiently_RB broad-based_JJ ,_, and_CC would_MD not_RB substitute_VB
            for_IN development_NN of_IN a_DT National_NNP Health_NNP Information_NNP
            Infrastructure_NNP ._.
            Non-governmental_NNP groups_NNS -_: especially_RB purchasers_NNS ,_,
            payors_NNS and_CC regulatory_JJ agencies_NNS -_: will_MD also_RB play_VB
            extremely_RB important_JJ roles_NNS in_IN developing_VBG incentives_NNS and_CC
            encouraging_VBG health_NN care_NN organizations_NNS to_TO improve_VB
            quality_NN and_CC adopt_VB safe_JJ practices_NNS ._. For_IN example_NN ,_, the_DT
            Leapfrog_NNP group_NN ,_, [_NN 52_CD ]_NN a_DT coalition_NN of_IN the_DT nation_NN 's_POS
            largest_JJS employers_NNS ,_, has_VBZ identified_VBN three_CD practice_NN -_:
            computerized_JJ physician_NN order_NN entry_NN ,_, evidence-based_JJ
            hospital_NN referral_NN for_IN high-risk_JJ procedures_NNS ,_, and_CC
            intensive_JJ care_NN unit_NN physician_NN staffing_NN -_: that_IN they_PRP
            believe_VBP will_MD substantially_RB improve_VB safety_NN ._. Although_IN
            there_EX are_VBP issues_NNS with_IN each_DT ,_, many_JJ organizations_NNS in_IN the_DT
            areas_NNS they_PRP have_VBP targeted_VBN are_VBP actively_RB considering_VBG
            adopting_VBG these_DT practices_NNS ,_, and_CC this_DT is_VBZ likely_JJ a_DT result_NN
            of_IN their_PRP$ activities_NNS [_NN 52_CD ]_NN ._. Payors_NNP can_MD adopt_VB
            contracting_VBG and_CC reimbursement_NN strategies_NNS that_WDT reward_NN
            organizations_NNS that_WDT use_NN IT_PRP more_RBR effectively_RB -_: for_IN
            example_NN ,_, submitting_VBG claims_NNS electronically_RB ._. Regulatory_NNP
            agencies_NNS can_MD ask_VB for_IN quality_NN measurement_NN data_NNS that_WDT are_VBP
            meaningful_JJ ,_, standardized_JJ and_CC are_VBP more_RBR readily_RB gathered_VBD
            electronically_RB ._.
          
          
            Security_NNP and_CC confidentiality_NN
            Security_NNP and_CC confidentiality_NN in_IN information_NN
            technology_NN also_RB represent_VB an_DT urgent_JJ concern_NN ._. The_DT Health_NNP
            Insurance_NNP Portability_NNP and_CC Accountability_NNP Act_NNP (_( HIPAA_NNP )_)
            begins_VBZ to_TO address_VB this_DT area_NN ,_, [_NN 53_CD ]_NN but_CC has_VBZ many_JJ
            problems_NNS which_WDT will_MD need_VB to_TO be_VB resolved_VBN ,_, specifically_RB
            concerning_VBG the_DT nature_NN of_IN the_DT boundaries_NNS regarding_VBG what_WP
            is_VBZ permissible_JJ and_CC what_WP is_VBZ not_RB ;_: if_IN interpreted_VBN broadly_RB ,_,
            HIPAA_NNP could_MD make_VB clinical_JJ research_NN nearly_RB impossible_JJ [_NN
            47_CD ]_NN ._. More_JJR legislation_NN will_MD be_VB needed_VBN to_TO strike_VB an_DT
            effective_JJ balance_NN ._.
          
          
            Professional_JJ involvement_NN
            Physicians_NNPS ,_, nurses_NNS ,_, pharmacists_NNS and_CC other_JJ types_NNS of_IN
            health_NN care_NN providers_NNS all_DT need_VBP to_TO become_VB more_RBR involved_JJ
            in_IN advocating_VBG for_IN and_CC developing_VBG IT_PRP in_IN healthcare_NN and_CC
            electronic_JJ medical_JJ records_NNS ._. This_DT is_VBZ an_DT issue_NN both_DT at_IN
            the_DT local_JJ level_NN (_( within_IN institutions_NNS and_CC among_IN
            community_NN practitioners_NNS )_) and_CC for_IN professional_JJ and_CC
            organizational_JJ leadership_NN groups_NNS ._. While_IN some_DT groups_NNS
            such_JJ as_IN the_DT American_NNP Academy_NNP of_IN Family_NNP Physicians_NNPS have_VBP
            led_VBN in_IN this_DT area_NN with_IN their_PRP$ work_NN on_IN electronic_JJ medical_JJ
            records_NNS ,_, more_RBR often_RB such_JJ professional_JJ groups_NNS are_VBP behind_IN
            in_IN this_DT area_NN ._. To_TO deal_VB with_IN this_DT ,_, more_JJR attention_NN ,_,
            including_VBG funding_NN ,_, will_MD need_VB to_TO be_VB directed_VBN at_IN this_DT
            area_NN ._. To_TO be_VB effective_JJ ,_, development_NN and_CC implementation_NN
            of_IN new_JJ information_NN technologies_NNS must_MD speak_VB to_TO the_DT
            minute-to-minute_JJ needs_NNS of_IN all_DT types_NNS of_IN providers_NNS ._.
          
          
            Research_NNP
            Finally_RB ,_, while_IN a_DT great_JJ deal_NN is_VBZ known_VBN about_IN what_WP
            works_VBZ regarding_VBG using_VBG IT_PRP to_TO improve_VB quality_NN ,_, much_JJ
            remains_VBZ to_TO be_VB learned_VBN ,_, especially_RB regarding_VBG
            implementation_NN and_CC dissemination_NN of_IN systems_NNS ._. Key_JJ
            questions_NNS remaining_VBG include_VBP how_WRB best_JJS to_TO deliver_VB
            clinical_JJ decision_NN support_NN ,_, how_WRB much_JJ adjustment_NN of_IN
            guidelines_NNS is_VBZ needed_VBN for_IN local_JJ implementation_NN to_TO be_VB
            successful_JJ ,_, how_WRB clinical_JJ information_NN systems_NNS can_MD best_JJS
            be_VB implemented_VBN and_CC disseminated_VBN -_: especially_RB to_TO small_JJ
            hospitals_NNS and_CC community-based_JJ providers_NNS ,_, how_WRB patients_NNS
            can_MD best_JJS be_VB involved_VBN more_JJR than_IN they_PRP are_VBP ,_, and_CC the_DT role_NN
            of_IN the_DT Internet_NN and_CC other_JJ new_JJ technologies_NNS in_IN this_DT
            revolution_NN ._.
          
        
      
      
        Summary_NNP
        Healthcare_NNP in_IN the_DT U_NNP ._. S_NNP ._. today_NN is_VBZ inefficient_JJ ,_,
        error-prone_JJ ,_, and_CC of_IN variable_JJ quality_NN ._. Information_NN
        technology_NN has_VBZ the_DT potential_NN to_TO substantially_RB improve_VB care_NN
        by_IN bringing_VBG decision_NN support_NN to_TO the_DT point_NN of_IN care_NN ,_, by_IN
        providing_VBG vital_JJ links_NNS and_CC closing_NN "_'' open_JJ loop_NN "_'' systems_NNS ,_, and_CC
        by_IN allowing_VBG routine_JJ quality_NN measurement_NN to_TO become_VB reality_NN ._.
        Achieving_NNP this_DT potential_NN will_MD be_VB challenging_VBG ,_, and_CC is_VBZ far_RB
        from_IN guaranteed_VBN ,_, but_CC it_PRP is_VBZ possible_JJ ._. If_IN it_PRP is_VBZ to_TO occur_VB ,_,
        substantial_JJ investment_NN will_MD be_VB needed_VBN to_TO galvanize_VB this_DT
        change_NN ,_, probably_RB in_IN large_JJ part_NN from_IN the_DT federal_JJ government_NN ,_,
        with_IN development_NN of_IN a_DT national_JJ health_NN information_NN
        infrastructure_NN representing_VBG the_DT most_RBS important_JJ piece_NN of_IN the_DT
        puzzle_NN ._.
      
      
        Competing_VBG interests_NNS
        Dr_NNP ._. Bates_NNP has_VBZ received_VBN honoraria_NN for_IN speaking_VBG from_IN the_DT
        Eclipsys_NNP Corporation_NNP ,_, which_WDT has_VBZ licensed_VBN the_DT rights_NNS to_TO the_DT
        Brigham_NNP and_CC Women_NNP 's_POS Hospital_NNP Clinical_NNP Information_NNP System_NNP ._.
        The_DT hospital_NN no_RB longer_RB has_VBZ a_DT financial_JJ relationship_NN with_IN
        Eclipsys_NNP ._. Dr_NNP ._. Bates_NNP is_VBZ a_DT coinventor_NN on_IN Patent_NNP No_UH ._. 6029138_CD
        held_VBN by_IN Brigham_NNP and_CC Women_NNP 's_POS Hospital_NNP on_IN the_DT use_NN of_IN decision_NN
        support_NN software_NN for_IN medical_JJ management_NN ,_, licensed_VBN to_TO the_DT
        Medicalis_NNP Corporation_NNP ._. He_PRP holds_VBZ a_DT minority_NN equity_NN position_NN
        in_IN the_DT privately_RB held_VBN company_NN Medicalis_NNP which_WDT develops_VBZ
        web-based_JJ decision_NN support_NN for_IN radiology_NN test_NN ordering_VBG ,_, and_CC
        serves_VBZ as_IN a_DT consultant_NN to_TO Medicalis_NNP ._. He_PRP is_VBZ also_RB a_DT
        consultant_NN and_CC serves_VBZ on_IN the_DT advisory_JJ board_NN for_IN McKesson_NNP
        MedManagement_NNP ,_, a_DT company_NN which_WDT assists_VBZ hospitals_NNS in_IN
        preventing_VBG adverse_JJ drug_NN events_NNS ._. He_PRP is_VBZ on_IN the_DT clinical_JJ
        advisory_JJ boards_NNS for_IN Zynx_NNP Inc_NNP ._. ,_, which_WDT develops_VBZ
        evidence-based_JJ algorithms_NNS ,_, and_CC Voltage_NNP Inc_NNP ._. which_WDT compiles_VBZ
        information_NN on_IN compliance_NN for_IN drug_NN companies_NNS ._. He_PRP is_VBZ a_DT
        consultant_NN for_IN Alaris_NNP ,_, which_WDT make_VBP intravenous_JJ drug_NN delivery_NN
        systems_NNS ._.
      
    
  
